Characterisation of  NanoDot  optically stimulated luminescent dosimeters for in vivo radiotherapy dosimetry by Boyd, Christopher
University of Wollongong 
Research Online 
University of Wollongong Thesis Collection 
1954-2016 University of Wollongong Thesis Collections 
2016 
Characterisation of NanoDot optically stimulated luminescent dosimeters 
for in vivo radiotherapy dosimetry 
Christopher Boyd 
University of Wollongong, cb977@uow.edu.au 
Follow this and additional works at: https://ro.uow.edu.au/theses 
University of Wollongong 
Copyright Warning 
You may print or download ONE copy of this document for the purpose of your own research or study. The University 
does not authorise you to copy, communicate or otherwise make available electronically to any other person any 
copyright material contained on this site. 
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act 
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised, 
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe 
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court 
may impose penalties and award damages in relation to offences and infringements relating to copyright material. 
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the 
conversion of material into digital or electronic form. 
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily 
represent the views of the University of Wollongong. 
Recommended Citation 
Boyd, Christopher, Characterisation of NanoDot optically stimulated luminescent dosimeters for in vivo 
radiotherapy dosimetry, Masters of Science - Research thesis, School of Physics, University of 
Wollongong, 2016. https://ro.uow.edu.au/theses/4640 
Research Online is the open access institutional repository for the University of Wollongong. For further information 





Characterisation of NanoDot Optically Stimulated Luminescent 
Dosimeters for In vivo Radiotherapy Dosimetry 
 
*A thesis submitted in partial fulfilment of the 
requirements for the award of the degree 
 
Masters of Science - Research 
from 
University of Wollongong 
By 
Christopher Boyd, BMedRadPhys 
 






I CERTIFICATION  
I, Christopher M. Boyd, declare that this thesis, submitted in partial fulfilment of the 
requirements for the award of Masters of Science by Research, in the faculty of Engineering, 
University of Wollongong, is wholly my own work unless otherwise referenced or 
acknowledged. The document has not been submitted for qualifications at any other 
academic institution.  
 
Christopher M. Boyd 













Your smile lights up the world. 
Reminding me nothing worth 
Being proud of was ever easy.  
iii 
 
II ACKNOWLEDGEMENTS  
This thesis would not have been possible without the contribution, dedication and support of 
a number of people and I would like to take a moment to give much deserved thanks to 
these people. 
First and foremost, I would like to thank Jo McNamara for donating her time both 
supervising and guiding me throughout the project, including staying back after hours. Her 
dedication, attention to detail and vast knowledge will be an invaluable example to me 
throughout the rest of my career. I would also like to thank Kirbie Sloan and Stephen 
Dowdell for donating their time and guidance when I required it and being so willing to take 
a moment from their busy days to help me with any problem, big or small. 
I would particularly like to thank Adrian Rinks and the other staff at Shoalhaven Cancer Care 
Centre for allowing me access to their equipment to complete this thesis. 
Thank you to my academic supervisors, Dr Dean Cutajar and Prof Pete Metcalfe for so 
patiently working with me; especially through the difficulties I faced changing projects. 
Knowing you were only an email away gave me confidence that everything would be done 
right. Your knowledge and passion were inspiring and motivating throughout this thesis. 
Lastly, I’d like to thank Mum and Dad, not just for giving me somewhere to live for the past 
12 months or for putting up with the stressful times. But for being role models who gave me 
the freedom to choose my passion and the strength of character to make it a reality. You 
both showed me that with enough work anything was possible and you being there 




III TABLE OF CONTENTS 
I CERTIFICATION ................................................................................................................... 1 
II ACKNOWLEDGEMENTS ...................................................................................................... 3 
III TABLE OF CONTENTS .......................................................................................................... 4 
IV LIST OF EQUATIONS ........................................................................................................... 8 
V LIST OF FIGURES ............................................................................................................... 10 
VI LIST OF TABLES ................................................................................................................. 12 
VII ABSTRACT ......................................................................................................................... 13 
VIII LIST OF ABBREVIATIONS .................................................................................................. 14 
1. INTRODUCTION .............................................................................................................. 1 
1.1 Radiotherapy .......................................................................................................... 1 
1.2 Treatment Planning................................................................................................ 1 
1.3 Dosimetry ............................................................................................................... 2 
1.4 Thesis Aims ............................................................................................................. 4 
1.5 Overview of Thesis ................................................................................................. 5 
2. LITERATURE REVIEW ...................................................................................................... 6 
2.1 Interactions of Photons with Matter ..................................................................... 6 
2.1.1 Attenuation coefficients ................................................................................ 7 
2.1.2 Atomic Number .............................................................................................. 9 
2.1.3 The Photoelectric Effect ............................................................................... 11 
2.1.4 Incoherent Scattering – The Compton Effect .............................................. 13 
2.1.5 Pair Production ............................................................................................ 15 
2.1.6 Coherent (Rayleigh) Scattering .................................................................... 16 
2.1.7 Bremsstrahlung ............................................................................................ 16 
v 
 
2.2 Passive in vivo dosimeters ................................................................................... 18 
2.2.1 Optically Stimulated Luminescent Dosimeters ............................................ 18 
2.2.2 Thermoluminescent Dosimeters .................................................................. 20 
2.2.3 Radiophotoluminescent Glass Dosimeters .................................................. 24 
2.2.4 Radiation sensitive film ................................................................................ 24 
2.2.5 Radiation sensitive gels ................................................................................ 26 
2.3 Real-time in vivo Dosimeters ............................................................................... 27 
2.3.1 Ionisation Chambers .................................................................................... 27 
2.3.2 Diamond Dosimeters ................................................................................... 28 
2.3.3 Metal Oxide Semiconductor Field Effect Transistor Dosimeters ................. 28 
2.3.4 Dosimetry using Electronic Portal Imaging Devices ..................................... 30 
2.4 Properties of Clinical Dosimeters ......................................................................... 30 
2.4.1 Fading ........................................................................................................... 30 
2.4.2 Sensitivity ..................................................................................................... 31 
2.4.3 Angular Dependence .................................................................................... 32 
2.4.4 Energy Dependence ..................................................................................... 33 
2.4.5 Tissue Equivalence ....................................................................................... 33 
3. EXPERIMENTAL INVESTIGATION .................................................................................. 34 
3.1 Introduction and Materials .................................................................................. 34 
3.2 Preliminary Investigation  - Annealing Tests ........................................................ 36 
3.2.1 Aim ............................................................................................................... 36 
3.2.2 Materials and Method ................................................................................. 37 
3.2.3 Results .......................................................................................................... 38 
3.2.4 Discussion ..................................................................................................... 41 
3.3 Preliminary Investigation  - Batch Sensitivity ....................................................... 41 
3.3.1 Aim ............................................................................................................... 42 
3.3.2 Materials and Method ................................................................................. 42 
3.3.3 Results .......................................................................................................... 43 
3.3.4 Discussion ..................................................................................................... 45 
4. DOSIMETER PROPERTIES ............................................................................................. 47 
vi 
 
4.1 Short Term Fading ................................................................................................ 47 
4.1.1 Introduction ................................................................................................. 47 
4.1.2 Aim ............................................................................................................... 47 
4.1.3 Materials and Method ................................................................................. 48 
4.1.4 Results .......................................................................................................... 49 
4.1.5 Discussion ..................................................................................................... 49 
4.2 Signal Loss Per Readout ....................................................................................... 51 
4.2.1 Introduction ................................................................................................. 51 
4.2.2 Aim ............................................................................................................... 51 
4.2.3 Materials and Method ................................................................................. 51 
4.2.4 Results .......................................................................................................... 52 
4.2.5 Discussion ..................................................................................................... 52 
4.3 Reproducibility ..................................................................................................... 54 
4.3.1 Introduction ................................................................................................. 54 
4.3.2 Aim ............................................................................................................... 54 
4.3.3 Materials and Method ................................................................................. 54 
4.3.4 Results .......................................................................................................... 56 
4.3.5 Discussion ..................................................................................................... 58 
4.4 Dose Linearity....................................................................................................... 59 
4.4.1 Introduction ................................................................................................. 59 
4.4.2 Aim ............................................................................................................... 59 
4.4.3 Materials and Method ................................................................................. 59 
4.4.4 Results .......................................................................................................... 60 
4.4.5 Discussion ..................................................................................................... 60 
4.5 Dose Rate Dependence ........................................................................................ 61 
4.5.1 Introduction ................................................................................................. 61 
4.5.2 Aim ............................................................................................................... 61 
4.5.3 Materials and Method ................................................................................. 61 
4.5.4 Results .......................................................................................................... 62 
4.5.5 Discussion ..................................................................................................... 62 
vii 
 
4.6 Angular Dependence ............................................................................................ 64 
4.6.1 Introduction ................................................................................................. 64 
4.6.2 Aim ............................................................................................................... 64 
4.6.3 Materials and Method ................................................................................. 64 
4.6.4 Results .......................................................................................................... 67 
4.6.5 Discussion ..................................................................................................... 67 
4.7 Depth Dose Curve ...................................................................................................... 68 
4.6.6 Introduction ................................................................................................. 68 
4.6.7 Aim ............................................................................................................... 68 
4.6.8 Materials and Method ................................................................................. 68 
4.6.9 Results .......................................................................................................... 70 
4.6.10 Discussion ..................................................................................................... 71 
5. MEPITEL® FILM ............................................................................................................. 73 
5.1 Effect of Mepitel® Film on surface dose .............................................................. 73 
5.1.1 Introduction ................................................................................................. 73 
5.1.2 Aim ............................................................................................................... 75 
5.1.3 Materials and Method ................................................................................. 75 
5.1.4 Results .......................................................................................................... 75 
5.1.5 Discussion ..................................................................................................... 76 
6. CONCLUSION ................................................................................................................ 77 




IV LIST OF EQUATIONS 
Equation 1: The Beer-Lambert law of light absorption ............................................................. 7 
Equation 2: Relative magnitude of attenuation coefficients ..................................................... 8 
Equation 3: Expressions for mass energy transfer coefficient ................................................... 8 
Equation 4: Relationship between mass energy transfer coefficient and mass energy 
absorption coefficient ................................................................................................................ 9 
Equation 5: Determination of effective atomic number ........................................................... 9 
Equation 6: Total Photon interaction cross section ................................................................. 10 
Equation 7: Calculation of effective atomic number ............................................................... 10 
Equation 8: Photoelectric interaction cross-sections .............................................................. 11 
Equation 9: Kinetic energy of Photoelectron ........................................................................... 12 
Equation 10: Compton conservation of energy and momentum ............................................ 13 
Equation 11: Angular dependent form of Compton Scatter Equation, where h is Planck’s 
constant, ν is frequency, p is linear momentum and c is speed of light in ms-1 ...................... 13 
Equation 12: Compton relationship of photon wavelength .................................................... 13 
Equation 13: Compton interaction equation ........................................................................... 14 
Equation 14: Klein-Nishina formula for scattering cross section ............................................. 14 
Equation 15: Atomic cross section of Rayleigh scattering ....................................................... 16 
Equation 16: Fraction of energy loss by Bremsstrahlung to total energy loss ........................ 17 
Equation 17: Relation of signal Intensity to temperature for LiF:Mg,Ti TLD ........................... 22 
Equation 18: Optical Density (OD) where I0 is light intensity without film and I is intensity 
with film present ...................................................................................................................... 25 
Equation 19: Homogeneous dosimeter energy dependence .................................................. 33 
Equation 20: Relation between Standard Deviation (σ), average (< >) of values (x) and total 
number of values (n) [5] .......................................................................................................... 37 
ix 
 
Equation 21: Derivation of 95% confidence interval used in error expression [5] .................. 38 
Equation 22: Decay function of dosimeter 645 84M ............................................................... 53 
Equation 23: Decay function of dosimeter 647 45I ................................................................. 53 
Equation 24: Decay function of dosimeter 647 26K ................................................................ 53 
Equation 25: Decay function of dosimeter 645 19J ................................................................. 53 
Equation 26: Decay function of dosimeter 047 33W ............................................................... 53 
Equation 27: Average Rate of signal loss per readout ............................................................. 53 
Equation 28: Correction factor, k, for ionisation chambers .................................................... 55 





V LIST OF FIGURES 
Figure 1: Energy and Z dependence of photon interactions [5] ................................................ 6 
Figure 2: Mass attenuation coefficients, total attenuation and total absorption [14] .............. 7 
Figure 3: Variation of effective atomic number from 10keV-100GeV [20] ............................. 11 
Figure 4: Photoelectric effect (Adapted from Fig 5.5) [22] ...................................................... 12 
Figure 5: Illustration of the Compton Effect. Adapted from Kahn [22] ................................... 14 
Figure 6: Pair production process. Adapted from Kahn [22] ................................................... 15 
Figure 7: Schematic of mechanism of OSL interaction [28] ..................................................... 18 
Figure 8: Typical LiF:Mg,Ti glow curve, showing the individual peaks. Peak 6 is omitted [37] 22 
Figure 9: Properties of clinically useful TL dosimeters. Adapted from Mayles, Nahum and 
Rosenwald [10] ........................................................................................................................ 23 
Figure 10: Standard 0.6cc Farmer Ionisation Chamber [22] .................................................... 28 
Figure 11: Schematic of MOSFET dosimeter [52] .................................................................... 29 
Figure 12: Graph of fading of Al2O3:C OSLDs over time [35].................................................... 31 
Figure 13: Loss of sensitivity of OSL through multiple readings [56] ....................................... 32 
Figure 14: Landauer InLight microStar OSL readout system .................................................... 34 
Figure 15: Gammasonics® OSL manual annealing lighbox ...................................................... 36 
Figure 16: Background dose trend after repeated use (95% confidence interval) .................. 41 
Figure 17: Arrangement of OSLs in grid positioned in beam field (shown in yellow).............. 43 
Figure 18: 6 MV Batch Sensitivity Averages ............................................................................. 44 
Figure 19: 10 MV Batch Sensitivity Averages ........................................................................... 45 
Figure 20: Variation in sensitivity at 6 & 10MV for each dosimeter (%) (95% conf. int. not 
visible) ...................................................................................................................................... 45 
Figure 21: Experimental setup for 6 MV Short term fading .................................................... 48 
Figure 22: 6 MV Short Term Fading results with 95% confidence interval.............................. 49 
xi 
 
Figure 23: Signal loss per readout for 5 dosimeters ................................................................ 52 
Figure 24: Reproducibility Setup .............................................................................................. 55 
Figure 25: Dosimeter 64549G variation over 10 readouts ...................................................... 56 
Figure 26: Dosimeter 64724O variation over 10 readouts ...................................................... 56 
Figure 27: Dosimeter 57183U variation over 10 readouts ...................................................... 57 
Figure 28: 0.6cc Farmer Ionisation chamber variation over 10 readouts................................ 57 
Figure 29: OSLD and 0.6cc Farmer Ionisation chamber linearity up to 800MU (Maximum error 
0.026%) .................................................................................................................................... 60 
Figure 30: Dose rate dependence ............................................................................................ 62 
Figure 31: OBI image of steel fiducial in Perspex cylinder ....................................................... 65 
Figure 32: Angular Dependence Jig (The University of Wollongong) ...................................... 65 
Figure 33: Angular Dependence Setup .................................................................................... 66 
Figure 34: Angular Dependence of OSLDs ............................................................................... 67 
Figure 35: Depth Dose Setup ................................................................................................... 69 
Figure 36: Sheet of EBT3 with 3cm grid marked out ............................................................... 70 
Figure 37: EBT3 Radiochromic film calibration curve (Maximum error 1%) ........................... 70 
Figure 38: OSL, EBT3 and Attix Ion Chamber normalised depth dose at 6MV (95% conf. int. 
not visible) ................................................................................................................................ 71 
Figure 39: Build up effect of Mepitel® Film measured using OSL and Attix Ionisation Chamber 





VI LIST OF TABLES 
Table 1: Initial OSL annealing results ....................................................................................... 38 
Table 2: 12hr anneal of used dosimeters................................................................................. 39 
Table 3: Initial and Final dose of 24hr anneal .......................................................................... 40 






Al2O3:C has increasingly been used for optically stimulated luminescence (OSL) dosimetry, 
initially for personal dosimeters and more recently through the Landauer commercial OSL 
system for dosimetry. The system couples the InLight® microStar reader with NanoDot® 
dosimeters that were then paired with a GammaSonics® manual annealing lightbox to 
perform robust, simple and reliable dosimetry.  
Using this system, an extensive list of properties relevant to NanoDot® use in a clinical 
environment was determined. These include: thorough annealing using this setup requires 
dosimeters to be in the lightbox for 36hrs; batch sensitivities were determined for 6 and 10 
MV to be between 1.038 and 0.963 with little difference in values seen between energies; 
20% fading was observed in the initial 30 minutes following exposure with stable readings for 
the next 48 hrs; 0.05% signal loss was observed per readout, indicating a large number of 
readouts are possible before statistically significant dose loss; dose reproducibility was found 
to be 4.17 ± 0.998% (2SD); linearity was observed from 0-500cGy with supralinearity 
observed beyond 500cGy; 5% dose rate dependence was observed between 100MU/min 
and 600MU/min; ±4% angular dependence was observed across the range of 360o; 
NanoDots® were found to over respond by 164% compared to EBT3 film at the surface. 
NanoDots® were used to investigate the dose build up effect of Mepital® film when applied 
for moist desquamation and erythema prevention. Whilst it was found that the presence of 
film did increase the surface dose, an accurate value could not be determined using OSL, 
however Attix chamber investigation determined this effect to be 25.68% at 6 MV and 
19.42% at 10 MV. Overall, it is expected that NanoDots® provide a useable alternative 
dosimetry method and could be used clinically.  
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As one of the primary treatment methods of Australia’s leading cause of death, radiotherapy 
is a critical technology to the medical field as a whole. With 326,600 people (or 
approximately 1.5% of the total population) having cancer at the time of the last health 
census, [1] improvement in the fields of radiotherapy treatment delivery and patient comfort 
have the possibility of directly or indirectly improving the lives of a large number of people. 
One of the appeals of cancer treatment by radiotherapy is the amount of understanding of 
the interaction of radiation with tissue. Since the discovery of the X-ray by Wilhelm Rontgen 
on the 8th of November 1895 [2], study has continued on the interaction of radiation with 
tissue. Radiation induced generation of free radicals and their toxicity to cancerous tissue, as 
well as a sound understanding of the radiosensitivity of each tissue type (see ICRP 103 [3]), 
enable radiation oncologists, therapists and physicists to deliver a treatment with maximum 
TCP and minimal NTCP. Additionally, the wide variety of radiotherapy delivery modalities 
such as: VMAT, IMRT, IMAT, Brachytherapy and more, give clinical staff a range of options to 
limit the exposure of normal tissue. [4] 
1.2 Treatment Planning 
As a treatment modality, the primary goal of radiotherapy is to deliver a lethal dose to the 
tumour while minimising dose to the surrounding healthy tissue. To this end, each treatment 
delivery is highly personalised and extensively planned prior to delivery. Understanding the 
physical processes involved in radiation interaction with tissue allows medical physicists and 
radiation therapists to effectively deliver a radiotherapy regimen set out by a medical 
professional, however, a large number of variables make effective treatment planning an 
exceedingly difficult task. 
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The ICRU 50 report is an extremely important document in the standardisation of photon 
beam delivery. ICRU 50 provides guidance in the prescription, recording and reporting of 
photon therapy by outlining and defining quantities and terms used in treatment. The report 
recommends a general dose uniformity of +7% and -5%, however these numbers are 
designed to be used as a guide [5]. Often, radiotherapy treatments include one or more 
“critical structures” or organs at risk. These are regions in or adjacent to the beam path with 
high sensitivity to radiation, such as the eye in nasopharyngeal treatments or the rectum in 
prostate treatment. A list of critical structures can be found in ICRU 50 and 62, however this 
cannot be considered comprehensive and critical structures need to be considered based on 
treatment type and patient status [5].  
Due to the nature of critical structures, dose to these areas needs to be carefully considered 
in the treatment planning phase. For rigorousness however, it is common to monitor critical 
structures with an appropriate dosimeter throughout treatment delivery. 
1.3 Dosimetry 
Dosimetry is defined by Dorland’s Medical Dictionary for Health Consumers Elsevier [6] as:  
“Scientific determination of the amount, rate, and distribution of radiation emitted from a 
source of ionizing radiation, in biological definition, measuring the radiation induced changes 
in a body or organism, and in physical definition, measuring the levels of radiation directly 
with instruments.” 
This definition shows the broad nature of dosimetry as a field and the importance of 
accurate dosimetry in a large number of medical and industrial tasks. In the context of 
radiotherapy however, there exists two steps in which dosimetry plays a critical role. The 
first is during the treatment planning phase, the role of which has been discussed; the 
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second is the in vivo dosimetry during treatment delivery, in which OSLDs will primarily be 
used. 
The motivation for in vivo dosimetry is complex but is best summarised in Metcalfe, Kron and 
Hoban [7]: 
i. Increasing complexity of equipment providing more room for error 
ii. Increasing difficulty of treatment techniques such as gating, VMAT and IMRT 
iii. Tighter dose rationale due to improvement in the understanding of both the target 
tissues and the biological effects of ionising radiation 
iv. More thorough follow up and less “routine” side effects make identification of side 
effects and secondary tumours more likely. 
v. Increased emphasis on liability and an ever more litigious culture means a thorough 
and accurate record of dose distribution during treatment is an important part of 
hospital protection. 
Current radiotherapy dosimetry is complex to discuss due to the most suitable dosimeter for 
a measurement not always being the same. Instead, it is up to the physicist to determine the 
best dosimeter on a case-by-case basis. Despite this, there are a number of dosimeters which 
are widely used. These include a number of ionisation chambers (such as Thimble, Parallel 
Plate and Farmer), radiation sensitive film (EBT-2 and EBT-3), MOSFET semiconductor 
dosimeters, as well as diamond, gel, alanine and plastic scintillation dosimeters. Each has a 
unique set of advantages and disadvantages, making them appropriate for certain situations. 
[5, 8-10] 
The final type of dosimeter is luminescence based dosimetry, both thermoluminescent and 
optically stimulated luminescent. The first type, thermoluminescent dosimetry, requires 
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careful handling, preparation and readout to use heating to release photons that are 
proportional to a dose of radiation.  
The second type, Optically Stimulated Luminescent (OSL) dosimetry uses robust detectors 
with extremely quick and simple preparation and readout procedures. As with 
Thermoluminescent Dosimeters (TLDs), OSL dosimetry uses release of photons proportional 
to dose as a measurement method. Unlike TLD however, OSL dosimetry uses lasers to 
stimulate release of these photons instead of heat.  OSL dosimeters themselves have 
different properties depending on the crystal from which they are manufactured. Although 
Al2O3:C (Carbon doped aluminium oxide) is the most clinically prevalent, a variety of other 
materials which exhibit OSL are used, including but not limited to, terbium dosed fluoride-
phosphate glass as well as crystals of LiF and BeO.  [5, 11-13] 
1.4 Thesis Aims 
The research goals are to provide an accurate and comprehensive reference of the 
properties and use of NanoDot® OSLDs. This will be achieved by: 
i. A thorough breakdown of dosimeter properties important for clinical 
dosimetry. 
ii. Initial investigation into clinical use of a NanoDot® OSL system including 
annealing time and time before readout. 
iii. Calculation of each clinically important property through careful 
experimentation. 
iv. Recommendation on the magnitude of important dose response 
properties 
v. Demonstration of use of NanoDot® OSLDs being used clinically for 
investigation of Mepitel® film. 
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1.5 Overview of Thesis 
Chapter 1 introduces the focus areas of the thesis and a brief explanation of the significance 
of these areas, both to the thesis and medical physics as a whole. Radiotherapy, treatment 
planning and dosimetry are each outlined to provide the reader with an understanding of 
the fields affected by this work. In addition to this the aims and outcome of this thesis are 
stated. 
Chapter 2 contains a thorough literature review; this is designed to be a self-contained 
background resource explaining basic interactions of radiation with matter, common 
detector types and uses as well as important properties of clinical radiotherapy dosimeters.  
Chapters 3, 4 and 5 contain the original research components of the thesis. Chapter 3 covers 
initial experiments relating to the day to day use of OSLDs. Chapter 4 systematically covers 
the aim, materials, method, results and discussion of the relevant detector properties. This is 
done through a series of sub chapters with each covering one property important to 
understand for safe use of OSLDs. Chapter 5 introduces Mepitel® film and a chapter covering 
research conducted into the effect of using Mepitel® film on the dose distribution. 
Chapter 6 summarises the overall findings of the research as well as relevant conclusions and 
possible future research prospects. This includes recommendations on the clinical use of 
NanoDot® OSLDs.  
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2. LITERATURE REVIEW 
2.1 Interactions of Photons with Matter 
 
The basis of all radiotherapy treatments is the transfer of energy from the radiation beam to 
the target volume, whilst sparing the surrounding healthy tissue as much as possible. 
Photons interact with matter in a number of different ways, depending on the composition 
of the material and the energy of the photons. Figure 1 summarises the energies of 
predominance for the three most clinically significant mechanisms of interaction; the 
Photoelectric Effect, the Compton Effect and Pair Production [5]. 
 
Figure 1: Energy and Z dependence of photon interactions [5] 
Figure 2 from Evans [14] shows the total contribution of each interaction to the total 
absorption in air from the Photoelectric and Compton Effects as well as Pair production. The 




Figure 2: Mass attenuation coefficients, total attenuation and total absorption [14] 
2.1.1 Attenuation coefficients 
Unlike electrons and other charged particles, photons do not continuously lose energy 
through Coulomb-force interactions, instead depositing most or all of their energy in a single 
interaction event. A number of similar but distinct quantities exist when talking about energy 
loss of a photon beam, the first of which is the probability that a photon will interact for a 
given path length, called the linear attenuation coefficient. The fraction of N0 particles lost 
over a unit dx is given in Equation 1, which gives a differential expression which integrated 
over a path length x gives the second expression, known as the Beer-Lambert Law: 
 𝑑𝑁0
𝑁0
=  −𝜇𝑑𝑥 
𝑁
𝑁0
=  𝑒−𝜇𝑥 
 (1)  
Equation 1: The Beer-Lambert law of light absorption 
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The mechanism of loss gives rise to two other attenuation coefficients, the linear energy 
transfer coefficient (µtr) which is a measure of the energy lost and the linear energy 
absorption coefficient (µab) which is a measure of the energy deposited in a material. Note 
that the energy transferred and the energy deposited are not the same, as shown in 
Equation 2: [7] 
 𝜇 < 𝜇𝑡𝑟 < 𝜇𝑎𝑏 (2)  
Equation 2: Relative magnitude of attenuation coefficients  
The linear attenuation coefficient characterises changes in the beam, but neglects the 
attenuating material. Since the composition of a material will affect the attenuation per unit 
path length, the linear attenuation coefficient is divided by the density to give a density 
independent quantity, the mass attenuation coefficient (µ/ρ). 
Similarly to the linear attenuation case, the mass attenuation coefficient deals with total loss 
per path length. The mass energy transfer coefficient represents the energy transfer per unit 


















Equation 3: Expressions for mass energy transfer coefficient  
In Equation 3, note that the overall mass energy transfer coefficient (
𝜇𝑡𝑟
𝜌
) is the sum of the 










)). The second expression gives the energy transfer coefficient (𝜇𝑡𝑟) which includes the 
average energy transferred into kinetic energy of particles per interaction, denoted 𝐸𝑡𝑟. 
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Possibly the most useful quantity for discussion of photon interactions with matter is the 
mass energy absorption coefficient. Like the linear absorption coefficient, this is a measure 
of the energy deposited in a material through the interactions of photon with matter 
discussed in 2.1.3, 2.1.4 and 2.1.5. The relationship between the mass energy transfer 
coefficient and the mass energy absorption coefficient is shown here, where g is the average 
fraction of energy not deposited to orbital electrons such as by bremsstrahlung and positron 






(1 − 𝑔) (4)  
Equation 4: Relationship between mass energy transfer coefficient and mass energy absorption 
coefficient  
Although calculation of mass energy absorption coefficients is difficult, extensive tables exist 
both online and in appendices of various textbooks. For comprehensive lists of mass 
attenuation coefficients, as well as further explanation of terms, see Attix [15] and NIST [16]. 
2.1.2 Atomic Number 
Figure 1 shows the dependence of interaction dominance against both photon energy and 
atomic number. This provides a simple comparison for single elements; the body 
composition varies drastically and is never a single element. As such, effective atomic 
number is used (Zeff) to provide a representation of the atomic number of the tissue for 
calculations. 











Equation 5: Determination of effective atomic number  
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However this simplistic form is described by Taylor [18] as a questionable approach, 
therefore it is only referred to in passing in contemporary literature. [19, 20] 
Equation 7 is just one of a variety used throughout the literature for determination of a more 
rigorous Zeff value using the total interaction cross section. The total photon cross section is 
given by Equation 6, from which it can be seen that the total cross section is a summation of 
the contributions of each interaction discussed above and 𝜎𝑝, where 𝜎𝑝is photonuclear cross 
section. These values themselves however are functions of mass attenuation coefficients, 
atomic and molecular weights as well as total number of molecules, resulting in an extremely 
intricate calculation. [20] 
 𝜎 =  𝜎𝑐 + 𝜎𝑖𝑛 + 𝜏 + 𝜅 + 𝜎𝑝 
 
(6)  





























Equation 7: Calculation of effective atomic number 
As well as the probability of different photon interactions changing with energy, the effective 
atomic number can also vary. Extensive investigation has been done into graphing the 
variation of effective Z across energy ranges due to its implications for radiotherapy [18, 21]. 





Figure 3: Variation of effective atomic number from 10keV-100GeV [20] 
2.1.3 The Photoelectric Effect 
The Photoelectric effect is the most probable method of interaction in low energy radiology 
such as Orthovoltage treatments. As shown in Figure 1, the cross section of interaction varies 
both with photon energy and atomic number while the Z of tissue is low and the energy of 
typical radiotherapy treatments being reasonably high. The cross section of this interaction is 
given in Equation 8. Although a number of variations are quoted in text the most common is 









Equation 8: Photoelectric interaction cross-sections  
The form used by Kahn is commonly referenced [8, 15] as this is the most practical 
approximation for high Z materials at low energy where the photoelectric effect is dominant. 
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The ratio given in differs from the mass attenuation coefficient (µ/ρ) discussed earlier as it is 
the photoelectric attenuation coefficient, rather than the mass attenuation coefficient. 
The photoelectric effect involves the transfer of a photon’s entire energy to a bound electron 
in an atoms inner K, L, M and N shells. The direction of the ejected electron depends on the 
angle and momentum of the incident photon. The ejected electron creates a vacancy in one 
of the inner shells and another electron drops from a higher shell to occupy this vacancy. The 
process of the electron filling this vacancy releases characteristic X-ray photons with a 
probability of releasing Auger electrons due to self-absorption of these X-rays. This process is 
summarised in Figure 4 [15, 22].  
 
Figure 4: Photoelectric effect (Adapted from Fig 5.5) [22] 
Given initial photon energy of hν interacting with a shell of bounding energy Eb the kinetic 
energy of the ejected photoelectron can be given in Equation 9: [15] 
 𝑇 = ℎ𝜈 − 𝐸𝑏 − 𝑇𝑎 (9)  
Equation 9: Kinetic energy of Photoelectron  
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Typically, the Ta is neglected as the kinetic energy given to the atom is approximately zero; 
however, it is included here for completeness. The photoelectron is ejected from the atom at 
a spectrum of angles depending on the momentum and angle of the incident electron. 
2.1.4 Incoherent Scattering – The Compton Effect 
Unlike the photoelectric effect, the process of incoherent scattering (referred to as the 
Compton Effect) is extremely important for most modern radiotherapy treatments. Unlike 
the Photoelectric effect, the Compton Effect is “the only interaction of importance from 
200keV to 2MeV” [7] for low Z materials such as tissue. Given its clinical importance and 
relevance, the Compton Effect will be discussed in detail, more detail may be obtained in 
[15, 23, 24]. 
The interaction between the photon and the isolated atomic electron causes a change in the 
energy and momentum of both the electron and the photon as given in Equation 10 and 11 
and illustrated in Figure 5: [15] 
                           𝐸 = ℎ𝜐 − ℎ𝜐′ (10) 
Equation 10: Compton conservation of energy and momentum  
 ℎ𝜐 = ℎ𝜐′ cos 𝜙 + 𝑝𝑐 cos 𝜃 
 
(11) 
Equation 11: Angular dependent form of Compton Scatter Equation, where h is Planck’s constant, ν is 
frequency, p is linear momentum and c is speed of light in ms
-1
 
This changing energy causes an associated change in wavelength according to the Planck 
equation which is given in Equation 12: [5] 
 Δ𝜆 =  𝜆𝐶(1 − cos 𝜃) (12) 
Equation 12: Compton relationship of photon wavelength  
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From these conditions it is possible to derive the well-known Compton equation relating the 
energy of the scattered photon, the initial photon and the electron. This is given in Equation 
13 where m0c
2











Equation 13: Compton interaction equation  
 
Figure 5: Illustration of the Compton Effect. Adapted from Kahn [22] 
The angle of the scattered photon is a useful quantity predicted by the differential scattering 
cross section, given by the Klein-Nishina formula shown here as , where r0
 is the radius of the 













𝛼2(1 − cos 𝜃)2




Equation 14: Klein-Nishina formula for scattering cross section  
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The minimum and maximum energy transfers occur with photon scattering angles of 0o and 





2.1.5 Pair Production 
The third primary photon interaction, pair production, involves the spontaneous generation 
of an electron positron pair due to the energy mass equivalence. At the end of its range, the 
positron recombines with an electron to produce two 0.511MeV photons. These photons are 
ejected in opposite directions perpendicular to the propagation of the positron to conserve 
momentum. Figure 6 illustrates the generation of the electron-positron pair with the 
annihilation occurring outside the diagram [22]. 
 
Figure 6: Pair production process. Adapted from Kahn [22] 
The rest masses of both an electron and positron are 0.511MeV; which provides a threshold 
for pair production to occur of 2 ×  0.511MeV =  1.022MeV. Any photons below this 
energy will not cause pair production and any energy above this will be given as kinetic 
energy after generation. Due to the relatively low energy of radiotherapy treatment, pair 
production is not a clinically significant interaction for treatment. However, it is important in 
PET imaging used for treatment planning. [8]. 
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2.1.6 Coherent (Rayleigh) Scattering 
Although not contributing to the energy transfer coefficient, Rayleigh scattering contributes 
to the attenuation coefficient. Unlike the Compton Effect, Rayleigh scattering occurs 
between a photon and a bound electron, meaning the interaction affects the entire atom. 
Rayleigh scattering is elastic in that the photon loses basically no energy, but is slightly 
deflected and the atom shifts enough to conserve momentum. Although occurring at all 
energies, the deflections are small and decrease with increasing energy. The interaction 
causes no transfer of energy and as such does not directly contribute to dose or kerma. 
The cross section for Rayleigh scattering is given in Equation 15 and like other photon 
interactions depends both on the energy of the photon and the atomic number, where k is a 








Equation 15: Atomic cross section of Rayleigh scattering  
2.1.7 Bremsstrahlung 
Although primarily significant in generation of clinical X-ray beams, the process of 
Bremsstrahlung is included here as important background information. For further reading 
on the production of radiation by Bremsstrahlung, further information may be found in [25, 
26]. 
The deceleration of an electron by interaction with a nucleus causes radiative energy loss in 
the form of a photon. The maximal energy of this photon cannot exceed the initial energy of 
the electron due to energy conservation and the closer proximity to the nucleus the greater 
the energy loss. For an electron beam, this generates a spectrum of radiative energy loss. For 
a target with minimal scatter and variation in stopping power, the fraction of energy loss 
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through Bremsstrahlung is given by Equation 15. Ee is the energy of the electron in MeV and 
n is a material specific energy dependent value, which for Tungsten (a common target for X-



















In vivo dosimeters are separated into two categories depending on the method of operation: 
passive and active (real time) dosimeters. 
2.2 Passive in vivo dosimeters 
Passive dosimeters accumulate dose over time and upon readout the signal intensity is 
proportional to the radiation exposure. 
2.2.1 Optically Stimulated Luminescent Dosimeters 
Optically stimulated luminescence (OSL) refers to the process by which electrons are freed 
from a semiconducting material through exposure to light. OSL has a number of applications, 
both for clinical dosimetry and for geological investigations such as dating i.e. estimating the 
age of a sample. When applied to clinical dosimetry, OSL dosimeters (OSLDs) are particularly 
useful due to their good tissue equivalence, insensitivity to mechanical and thermal changes 
and stable radiation sensitivity [27]. Figure 7 illustrates the mechanism of OSL where the 
traps between the conduction and valence bands are produced by doping a pure 
semiconducting material with small amounts of impurities. 
 




A variety of materials exhibit OSL and investigation into each is ongoing, some materials 
which have been examined for use in clinical dosimetry include CaS:Ce,Sm, Al2O3:C [29], 
CaF2:Tm [30] and BeO [12] as well as a variety of others. Pingqiang et al. found that up to 
5Gy/s for a total dose of 10Gy delivered to CaS:Ce,Sm OSLDs no dose-rate effect was shown 
on output. Similar results were found for Al2O3:C “influencing factors such as beam quality, 
dose rate, field size and irradiation temperature did not affect the OSLD response by more 
than 1%” [31]. 
LiF OSLDs were found to accurately measure from <1Gy to up to 5 X 104Gy, such as those 
doses used in radiation sterilisation. For the BeO dosimeter, doses over 10Gy caused some 
saturation however, “deviation to linearity is fewer than 5% at 30Gy” [27]. For low doses, it 
was theorised that using a 405nm diode for readout, the lowest level of detection (LLD) 
could be reduced below 1µGy. It was noted by Sommer that OSLDs produced from BeO 
underestimate radiation under 100keV. In addition to this, some self-absorption occurs 
below 10keV, although build up foils can compensate the change in energy response. 
However, it has been found that for Al2O3:C OSLDs, response can be considered 
approximately linear up to 50Gy and sublinearity occurs for accumulated doses above 
100Gy[30].  
The use of OSLDs for dosimetry of proton and heavy ion beams is also being investigated. 
One of the primary difficulties in proton and heavy ion dosimetry is a result of the variation 
in the Linear Energy Transfer (LET) along the path length, resulting in variation of the OSL 
efficiency. It was concluded however that strip readers showed promise in measurement of 
lateral profiles [30]. 
Despite the wide variety of materials exhibiting OSL properties, Al2O3:C is primarily chosen 
for clinical dosimetry and will be used in this work. The primary application of these 
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dosimeters is for use as in vivo dosimeters (meaning occurring in a natural setting, usually 
with reference to a living organism[32]). According to [33], in vivo dosimetry includes: 
i. Entrance Dose Measurements 
ii. Exit Dose Measurements 
iii. Transmission Measurements 
iv. Intracavity Absorbed Dose Measurements 
The primary dosimeters used in this study, are NanoDot® Al2O3:C dosimeters, from Landauer. 
These OSLDs are a 10mm x 10mm x 2mm chip of light tight plastic enclosing a small disc of 
Al2O3:C. This means they can easily and comfortably be secured to the patient, even using 
multiple dosimeters for radio sensitive areas such as the eye. Unlike many other dosimeters, 
the readout process is non-destructive and multiple readouts can be taken from one 
irradiation. 
 
2.2.2 Thermoluminescent Dosimeters 
Thermoluminescent detectors (TLDs) have been a common personal for almost 100 years 
[34]. TLDs are semiconductor based materials, most commonly LiF activated with 
combinations of Mg, Ti, Cu and P. The physical processes by which radiation interacts with 
TLD dosimeters is identical to OSL dosimeters. The incident radiation causes electrons to be 
excited into the conduction band of the semiconductor creating an electron-hole pair. The 
electron then drops to an intermediate energy level in the forbidden gap created by the 
doping. When read, energy is given to the electron, allowing it to move to a recombination 
centre, where it recombines with a hole. This process release photons, the quantity of which 
is proportional to the initial dose.  
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The difference between TLD and OSL however is the method of reading; TLD uses heat to 
cause recombination, whilst OSL uses light (typically a laser of a specific, known, 
wavelength). For LiF TLD dosimeters, readout is several hundred degrees whilst for Al2O3:C 
the typical wavelength used for readout is approximately 520nm with recombination 
emission of 420 and 330nm [30, 35]. The primary advantages of TL dosimeters over many 
other forms of detection include the lack of cables, enabling much more flexible positioning 
of the detector and the variety of TL materials which match different human tissues [10]. 
Unlike OSL’s however, TL dosimeters are renowned for being time consuming to readout and 
fiddly to ensure an accurate reading. Clinical radiotherapy departments which have a 
carefully developed procedure for using TL dosimeters can produce highly accurate readings; 
however this may require a staff member dedicated almost entirely to the task of 
maintaining and reading the dosimeters. 
One of the primary reasons for complication of readout comes from the intrinsic property of 
the crystal lattice. As the crystal is heated for readout, some electrons are liberated at lower 
temperatures whilst some require more heating to liberate. This phenomenon is described 
as a “glow curve”, with a typical LiF:Mg,Ti glow curve shown in Figure 8. The associated 
equation of this curve can be seen, however, the complexity of this equation makes using it 
for direct calculation prohibitively difficult. Equation 17 is derived from an assumption of first 
order kinetics and is applicable for all phosphorescence, the full derivation can be found in 




Figure 8: Typical LiF:Mg,Ti glow curve, showing the individual peaks. Peak 6 is omitted [37] 
 
 
















Equation 17: Relation of signal Intensity to temperature for LiF:Mg,Ti TLD 
A properly set up TL system using LiF:MgTi or LiF:Mg,Cu,P can have a lowest level of 
detection (LLD) as low as 10 and 1µGy respectively with an error of ±2% [10]. While this 
would be excellent for use in clinical radiotherapy, a multi institutional study into the clinical 
use of TLDs found that 22% of users had errors greater than 10%[38]. These two dopings of 
LiF represent the majority of clinical LiF isotopes with LiF:Mg,Ti being the primary TL material 
for many years and LiF:Mg,Cu,P being a relatively newer doping first developed in 1978 [38] 
for its higher sensitivity and more reliable response. The primary readout glow peak of 
LiF:Mg,Ti occurs at 195oC (peak V) and LiF:Mg,Cu,P occurs at 220oC (peak IV), both glow 
curves are complex due to the many contributing factors and isolating the relevant peak for 
readout is the primary challenge in ensuring accurate results. [39, 40] 
LiF TLDs have been used extensively throughout medical dosimetry due to their suitable 
properties, some of these are shown in Figure 9 from Mayles, Nahum and Rosenwald [10]. 
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Dosimetric Properties of Some TL Material 
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Figure 9: Properties of clinically useful TL dosimeters. Adapted from Mayles, Nahum and Rosenwald 
[10] 
All TLDs exhibit some form of signal fading which can vary significantly, depending on 
materials used as well as handling and readout procedures. The values quoted for fading 
reflect this dependence with no consensus in the literature, however a generally accepted 
value for LiF:Mg,Ti is <10% per year, for LiF:Mg,Cu,P however, fading is either within 
experimental uncertainty or not present [37, 38].  
Additionally, Figure 11 refers to region of linearity, for many TLDs the region of meaningful 
results includes some sections of sub- or supra- linearity. This can extend the practically 
useful dose range orders of magnitude for some TLDs. At extremely low doses (<5x10-5Gy) 
LiF:Mg,Ti exhibits an over response which shows as supralinearity, the same occurs at doses 
over 1Gy however LiF:Mg,Ti TLDs can be used for readings up to 103Gy. In the case of 
LiF:Mg,Cu,P no supralinearity is observed, instead sublinearity occurs at energies around 
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150keV. The response of TLDs also changes over time and with use due to the accumulation 
of radiation damage, affecting the LLD and sensitivity of the detector [38, 41].  
LiF dosimeters are found to be both angular and dose rate independent, which removes the 
need for correction factors in their use as in vivo dosimeters. Their availability in multiple 
forms (rods, powder, ribbons, discs e.t.c) also allows their implementation for a variety of 
purposes including personal dosimetry, in vivo dosimetry and dose mapping. 
2.2.3 Radiophotoluminescent Glass Dosimeters 
Although first developed in the 1950’s, radiophotoluminescent glass dosimeters (RPLDs) 
have not been widely used [42]. This was primarily due to there being no way to readout 
RPLDs after low dose exposures; however the development of pulsed UV lasers have enabled 
much higher sensitivity and accuracy of measurements [43]. 
RPLDs work by radiation exposure causing the formation of silver ion (Ag+ or Ag2+) 
luminescence centres within silver activated phosphate glass. These luminescence centres 
exhibit orange wavelength fluorescence when exposed to pulsed UV light. Similarly to OSLDs, 
the intensity of this fluorescence is related to the initial radiation exposure, however unlike 
OSLDs, there is no destruction of these luminescence centres in readout [5]. 
This means that RPLDs theoretically have no signal loss or fading, which combined with low 
angular dependence, high reproducibility, small size and wide dose range makes them 
excellent possible future in vivo dosimeters [42, 43]. 
2.2.4 Radiation sensitive film 




Radiographic film; consists of a silver bromide (AgBr) emulsion over a supporting polymer. 
This emulsion is sensitive to visible light as well as radiation and as such must be handled in 
darkened conditions prior to exposure. After exposure to radiation, the silver ions form what 
is termed “sensitivity specks” which vary in size depending on the radiation. These sensitivity 
specks form the basis of the latent image, which after development of the film, becomes 
visible. After being developed, radiographic film is fixed to prevent any further sensitivity 
specks forming and then washed to remove residual emulsion and development chemicals 
[10, 22, 44]. 
The silver centres present on the film change its optical density (OD) proportional to the 
incident radiation, where optical density is defined according to Equation 19: [8] 
 





Equation 18: Optical Density (OD) where I0 is light intensity without film and I is intensity with film 
present  
Radiochromic film works similarly to radiographic film, however instead of a silver bromate 
emulsion on a supporting polymer; radiochromic film consists only of a polymer containing a 
radiation sensitive dye. This has the substantial advantages of making radiochromic film 
comparatively insensitive to light whilst still being sensitive to gamma, x-ray and UV 
radiation as well as removing the intricate developing procedure, instead only a flatbed 
scanner with image analysis software is needed. Although not useable for absolute 
dosimetry, carefully calibrated radiochromic film can have ±3% precision and is also one of 
the few dosimetry methods providing a 2D dose map [22, 44].  
The use of EBT Grafchromic film for radiotherapy is a result of the improvement of the 
properties most limiting to the use of other films. The low energy dependence and accuracy 
of doses below 2Gy are both important features increasing the reliability of EBT film in 
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radiotherapy applications. A wide variety of Radiochromic film types have been used since 
their development in the late 1960’s including: XR-T, RTQA, XR-RV2, XR-QA. The differences 
in these films primarily centre on thicknesses and compositions of emulsions and sensitive 
layers. Variation of these factors changes the nominal dose range, thickness and sensitivity 
of the films allowing different uses. Whilst some of these films have been superseded, some 
can still be used today. [45, 46] 
The next step in Gafchromic film development was the EBT film with a relatively simple 
construction, sensitivity to a higher energy and all the desirable properties for use in 
radiotherapy, multiple iterations of this film have been produced as technology has 
improved with EBT3 the film currently used. 
2.2.5 Radiation sensitive gels 
As with radiation sensitive film, radiation sensitive gels (RSGs) undergo a chemical change 
when exposed to radiation. When exposed to radiation, RSGs undergo radiolysis and vinyl 
monomers combine to form polymers, often becoming visibly altered in the process. 
Despite the visible changes in RSGs, quantification of this can be difficult. MRI is the currently 
preferred method as the polymerisation process causes significant change in the spin-spin 
relaxation rate. The inhomogeneities in the external magnetic and radio fields become a 
source of inaccuracy if other MRI imaging modes are used. In addition to this, X-ray CT is 
ineffective as the polymerisation process causes a change in Hounsfield number of about 
1HU Gy-1 [47]. 
The chemistry of RSGs is complex and not covered here but the primary interest is the 
formation of free radicals and the interaction between terminated polymer chains, 
monomers and free radicals. Currently, RSGs require extensive work from staff to produce, 
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use and readout as well as access to expensive machines which have limited free time due to 
an already large clinical demand. 
Characteristically, the gel shows a dose rate dependence and energy dependence within the 
clinical range. This effect is more pronounced depending on the composition of the gel in 
use.  Additionally, the gels are not tissue equivalent and show some temperature 
dependence within the clinical range during irradiation. 
The primary advantage of gels is their ability to map dose in 3D, the same as is done by film 
in 2D. This is particularly useful for more complex treatments such as VMAT and IMAT, as 
well as 3D modelling of dose distribution in low and high dose rate brachytherapy. 
2.3 Real-time in vivo Dosimeters 
2.3.1 Ionisation Chambers 
The most extensively used and thoroughly understood of all dosimeters is the ionisation 
chamber. At its’ simplest, an ionisation chamber consists of a region where radiation 
interacts with a target (the sensitive volume) to produce secondary electrons. This process 
occurs under bias and produces a current proportional to the initial radiation. The total 
charge collected is thus proportional to the absorbed dose. 
The size, shape, bias voltage and sensitive volume vary depending on the intended use and 
are often calibrated for use as a reference dosimeter. The primary chamber used in clinical 
medical physics is the 0.6cm3 Farmer® thimble ionisation chamber which is pictured in Figure 
10. This chamber is particularly useful as there is a wealth of information known about the 




Figure 10: Standard 0.6cc Farmer Ionisation Chamber [22] 
2.3.2 Diamond Dosimeters 
As discussed previously, there are a number of properties that a detector must exhibit in 
order to be useful, especially in a clinical setting. Diamond is non-toxic, chemically inert, 
resistant to radiation damage and most importantly, near tissue equivalent. Synthetic 
diamond production by chemical vapour deposition (CVD) has significantly reduced the cost 
of diamond dosimeters. CVD Dosimeters have very high spatial resolution, high sensitivity 
and good tissue equivalence however some dose rate dependence and temporary loss in 
sensitivity was observed [49]. Although first investigations into diamond as a sensitive 
volume began in the 1940’s, not enough is understood about the appropriate factors and 
response for these dosimeters to be widely implemented. With further investigation 
however there may be an increase in their clinical application. 
2.3.3 Metal Oxide Semiconductor Field Effect Transistor Dosimeters 
MOSFET dosimeters are solid state transistors which use a change in the electrical 
characteristics of the junction to determine the incident dose. The potential required to 
generate a fixed value of current past the junction, the threshold voltage, increases in 
proportion to the incident dose. Depending on the calibration, sensitivities as high as 5x10-4 
Gy can be obtained from a single chip, with higher sensitivities possible through multiple 
dosimeter arrangements or variations of the oxide layer [8]. 
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When radiation is incident on a MOSFET dosimeter (shown in Figure 11) electron-hole pairs 
are produced in the silicon dioxide layer below the gate. Holes may become bound to traps 
in the silicon dioxide, influencing the flow of charge in the channel between the source and 
the drain. A positive bias on the gate encourages holes to be trapped closer to the interface 
between the silicon dioxide layer and the silicon substrate, increasing the effect of the 
trapped charges on the flow of current in the channel, and hence, increasing the sensitivity. 
This causes a change in the threshold voltage that is approximately linearly proportional to 
the initially incident dose [5, 8]. 
MOSFETs can be produced with extremely small sensitive volumes, giving high spatial 
resolution, are dose rate independent, can be used for immediate readout, are much easier 
to use than TLDs and can be used for doses up to 180Gy. However, when using MOSFETs a 
number of important considerations need to be made. These include: strong temperature 
dependence, accumulated dose dependence (typically making them unusable after 18500 
mV of accumulated dose), lack of tissue equivalence and variation in signal after irradiation 
[50, 51]. 
 
Figure 11: Schematic of MOSFET dosimeter [52] 
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2.3.4 Dosimetry using Electronic Portal Imaging Devices 
Electronic portal imaging devices (EPIDs) are a standard feature on all modern linacs and an 
integral part of their clinical operation. EPIDs typically consist of arrays of silicon along with a 
fluorescent material such as CsI and are commonly used to provide images for position 
verification [53]. Back projection algorithms, (similar to those used for CT image 
reconstruction) have enabled EPID images to be used to compare both the planned and 
delivered dose distributions. 
Depending on the pixel size, scatter of optical photons in the fluorescent material can cause 
incorrect binning of counts and in turn affect the 2D dose distribution developed through 
this method. This limits the spatial resolution of 2D EPID generated dose distributions 
however, Wendling, Louwe, McDermott, Sonke, van Herk and Mijnheer [54] found that EPID 
dose distributions were reliable even for more complex treatments such as IMRT. In 
addition, the availability, convenience and accuracy (within 2% of dose maximum) of EPIDs 
still make them promising detection method for clinical treatment [54].  
2.4 Properties of Clinical Dosimeters 
Characterisation of dosimeters is an important process prior to clinical implementation and 
involves thorough investigation into all relevant dosimeter properties. This includes 
gathering information about short and long term fading, sensitivity, angular, dose rate and 
energy dependences, dose linearity, batch homogeneity, tissue equivalence and spatial 
resolution. 
2.4.1 Fading 
Fading refers to the inherent loss of signal of a dosimeter over time and has two types, short 
and long term. Different dosimeters have different fading mechanisms and semiconductor 
dosimeters fade through spontaneous release of electrons from traps. 
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In the case of OSL, this can be enhanced through a non-zero ambient light level and as such 
OSLDs have significant short term fading, shown in Figure 7. The retention of signal after 
stabilising however was excellent for OSL with dosimeters average reading decreasing by 
approximately 1.8% from 17 to 38 days after irradiation, becoming stabilised after 27 days 
[55]. 
 
Figure 12: Graph of fading of Al2O3:C OSLDs over time [35] 
2.4.2 Sensitivity 
The relationship between detector signal and incident radiation under the same conditions is 
not always consistent. Repeated use of the same dosimeter can cause radiation damage to 
the system, decreasing the signal measured for each subsequent reading.  
For OSL, this is caused by destruction of the traps resulting in fewer electrons trapped and 
less light output on readout. This is shown in Figure 13 from Mrcela, Bokulic, Izewska, 
Budanec, Frobe and Kusic [56] in which detectors were exposed to 100 and 400cGy 100 




Figure 13: Loss of sensitivity of OSL through multiple readings [56] 
2.4.3 Angular Dependence 
The response of dosimeters can vary depending on their orientation to the radiation field; 
this is referred to as angular or directional dependence. Angular dependence is typically due 
to the detector construction and is a function of the incident energy. As such it is an intrinsic 
property of the system and needs to be accounted for in detector use [5].  
In the case of OSLs, the angular dependence of Al2O3:C dosimeters needs to be carefully 
considered in their clinical implementation. Readings were found to drop by as much as 70% 
for 25kVp mammography readings and 10-40% for X-ray and CT measurements with the 
least variation observed for CT [57]. In another study by Kerns, Kry, Sahoo, Followill and 
Ibbott [58], a 4% and 3% decrease in reading was observed for 6 and 18 MV beams 
respectively, this supported results found by using Al2O3:C dosimeters and 6 MV radiation 
fields [35]. This suggests that for clinical dosimetry, Al2O3:C dosimeters are best used for 
higher energy fields and placed as perpendicular to the field as possible. 
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2.4.4  Energy Dependence 
Energy dependence is a term regularly used throughout the literature but often poorly 
clarified. It is generally a ratio of detector response to a standardised response, such as 
response per unit absorbed dose in water or exposure in air from Co-60 reference radiation. 
In the context of OSL this refers to the number of electrons liberated for a given radiation 
energy in comparison to the reference [9]. Each definition of energy dependence is based on 
a number of fundamental assumptions regarding the nature of the interactions within the 
dosimeter and the existence of charged particle equilibrium (CPE). 
More broadly, energy dependence can be quantified as the ratio of the dosimeter reading to 
the dosimetric quantity, that is the reading displayed compared to the ideal reading[5]. An 
example of this is shown in Equation 16. The ratio is taken in comparison to response per 
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Equation 19: Homogeneous dosimeter energy dependence  
2.4.5 Tissue Equivalence 
Tissue equivalence refers to the radiation equivalence of the detector materials to water, a 
common approximation for a variety of soft tissues in the body. Tissue equivalence depends 
on the effective atomic number of the dosimeter, the quality of the radiation and a tissue 
equivalent detector can remove the need for correction factors and significantly reduce 




3. EXPERIMENTAL INVESTIGATION 
3.1 Introduction and Materials 
In order for a detector to be considered thoroughly characterised a wide array of properties 
need to be understood. For this study, several detector properties were examined separately 
through an individual experiment designed to isolate that particular property. The basic 
setup of each experiment involved an arrangement of solid water, one or more OSLDs and 
the Varian IX linear accelerator in operation at the Shoalhaven Cancer Care Centre. Readout 
was performed using a Landauer InLight microStar system (pictured in Figure 14) with the 
system operating in NanoDot® mode, after running initial tests, the manufacturer 
determined calibration factor of 1000 and crossover value (point at which weak stimulation 
is used to protect the PMT) were used.  
 
Figure 14: Landauer InLight microStar OSL readout system 
For many of the experiments, a control was needed with which the OSLD signal could be 
compared. To this end a, water tight, graphite tipped, 0.6cm3 Farmer ionisation chamber was 
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used. This chamber was used in the commissioning of the linear accelerator and also 
provided an effective method of ensuring the machine was operating correctly. 
Due to the different density of air and the effect of air on radiation transmission, a 1cm sheet 
of Superflab® was placed over the detector. The Superflab provided a tight contact with the 
detector to remove air gaps and also provided a smooth surface for the solid water placed 
above the detector. Although the density and composition of this material is not identical to 
the solid water or tissue, it is as close possible and is a commonly used clinical bolus material 
[61]. The remainder of the build-up region was then constructed from solid water to place 




3.2 Preliminary Investigation  - Annealing Tests 
OSLDs which have been irradiated have electrons trapped within their structure that provide 
the signal when readout occurs, however a detector which has residual signal on it would 
not be useful for future measurements. Like other solid state dosimeters, OLSDs can be 
“annealed” to allow them to be reused repeatedly until physical or radiation damage occurs. 
This process for OSLDs however is still being perfected for clinical application and current 
literature lists a variety of methods, from irradiation by 6 x FL-15 UV lamps [62] to 1 minute 
exposure with an endoscopic illuminator [35]. For this study, a Gammasonics® manual OSL 
annealing lightbox consisting of a one sided arrangement of fluorescent lamps was used to 
anneal (see Figure 15). 
 
Figure 15: Gammasonics® OSL manual annealing lighbox 
3.2.1 Aim 
The aim of this investigation was to determine the optimal time required for thorough 
annealing of the OSLDs due to limited literature being present on correct use of the supplied 
manual annealing lightbox. 
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3.2.2 Materials and Method 
Eight detectors were irradiated by 6 MV at 600MU/min and dmax then read out before being 
annealed for between 2 minutes and 2 hours to determine an optimal annealing time. The 
annealing process consisted of manually sliding the Al2O3:C sensitive volume out of the 
plastic casing and placing the open detector onto the surface of the lightbox shown in Figure 
15. The duration of the annealing process was determined by a timer on the front of the 
lightbox and after the lightbox was activated the detectors were exposed to low intensity 
fluorescent light for a prolonged period of time. Based on the Gammasonics® manual 
advising “UV Light from sources such as unshielded fluorescent lamps or sunlight can result 
in an increase in residual dose.” [63] only optical light is used in the annealing process; 
however light source information is deemed to be proprietary by the distributor. 
3.2.2.1.  Error Calculation 
To ensure data throughout this thesis is correctly represented, where possible associated 
errors are included. Errors were determined based on a normal distribution of data, to 
ensure a normal distribution the data range was compared to 3 times the standard deviation 
of the set. 
 
𝜎 = √




Equation 20: Relation between Standard Deviation (σ), average (< >) of values (x) and total number of 
values (n) [5] 
Given a normal distribution of data (such as is the case here), errors can be expressed using 
multiples of the standard deviation, called a confidence interval. Twice the standard 
deviation is used to give a 95% confidence interval. The 1.96 figure is obtained from an 
approximation of the Normal cumulative distribution function [64]. 
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 95% 𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑟𝑣𝑎𝑙 = 1.96 ∗ 𝜎 (21) 
Equation 21: Derivation of 95% confidence interval used in error expression [5] 
 
3.2.3 Results 
At low annealing times, minimal dose was removed and as such some detectors were 
annealed repeatedly with dose variations recorded 
Table 1 shows the results of a variety of annealing times, these dosimeters were irradiated 
through the course of becoming accustomed to the equipment and experimental conditions 
for these exposures varied. The detectors used for previous experiments were annealed for 
12hrs in an attempt to remove residual dose and this is shown in Table 2. 





Initial Dose (cGy) Final Dose (cGy) Percent Annealed 
(%) 
64904K 120 206.53 ± 4.75 130.46 ± 3.00 36.83 
64904K 536 130.46 ± 3.00 20.61 ± 0.47 84.20 
86738A 120 205.54 ± 4.73 147.06 ± 3.38 28.45 
86738A 1176 120.65 ± 2.77 6.33 ± 0.15 94.75 
64523U 1800 194.86 ± 4.48 7.89 ± 0.18 95.95 
04733W 3000 188.06 ± 4.33 3.81 ± 0.09 97.97 
37973M 5400 200.77 ± 4.62 1.29 ± 0.03 99.36 




Table 2: 12hr anneal of used dosimeters 
Dosimeter Number Initial Dose (cGy) Final Dose (cGy) Percent Annealed (%) 
333602 205.78 ± 4.73 1.76 ± 0.04 99.14 
60947D 204.77 ± 4.71 7.93 ± 0.18 96.13 
36347O 199.93 ± 4.60 1.61 ± 0.04 99.19 
64345S 199.01 ± 4.58 1.17 ± 0.03 99.41 
60892K 197.4 ± 4.54 1.71 ± 0.04 99.13 
86890I 197.3 ± 4.54 1.48 ± 0.03 99.25 
60877C 196.59 ± 4.52 1.18 ± 0.03 99.40 
64885C 195.11 ± 4.49 1.59 ± 0.04 99.19 
64754J 194.97 ± 4.48 1.24 ± 0.03 99.36 
64726K 191.44 ± 4.40 0.84 ± 0.02 99.56 
94519J 190.77 ± 4.39 1.75 ± 0.04 99.08 
64584M 189.61 ± 4.36 1.23 ± 0.03 99.35 
64745I 185.85 ± 4.27 0.94 ± 0.02 99.49 
57193T 93.03 ± 2.14 0.81 ± 0.02 99.13 
86891G 47.43 ± 1.09 0.25 ± 0.01 99.47 
64904K 17.22 ± 0.40 0.97 ± 0.02 94.37 
60860R 8.35 ± 0.19 0.64 ± 0.01 92.34 
64523U 7.64 ± 0.18 1.12 ± 0.03 85.34 
86738A 6.22 ± 0.14 0.83 ± 0.02 86.66 
04733W 3.75 ± 0.09 0.9 ± 0.02 76.00 
56838C 3.51 ± 0.08 0.14 ± 0.01 96.01 
37973M 1.24 ± 0.03 0.46 ± 0.01 62.90 
64722Q 1.012 ± 0.02 0.099 ± 0.01 90.22 
57007W 0.51 ± 0.01 0.34 ± 0.01 33.33 
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Based on the average of 5 unirradiated dosimeters background reading being 
0.054±0.0027cGy, an annealed dosimeter was defined as one with no reading greater than 
0.1cGy. This limit was chosen to improve precision, particularly for low dose measurements. 
As such, based on the results shown in Table 2, a third experiment was designed in which a 
set of 5 dosimeters were irradiated by 6 MV at 600MU/min when positioned at 1.5cm depth 
for 200MU (expected to give a dose of 200cGy). These detectors were then annealed for 
24hrs and the results (in Table 3) showed all dosimeters were below the 0.1cGy limit 
indicating that this would be appropriate for further experiments. 
Table 3: Initial and Final dose of 24hr anneal 
Dosimeter Number Initial Dose (cGy) Final Dose (cGy) 
64724O 201.32 ± 4.63 0.028 ± 0.001 
875698 203.17 ± 4.67 0.041 ± 0.001 
64549G 200.11 ± 4.60 0.042 ± 0.001 
64543S 207.43 ± 4.77 0.036 ± 0.001 
57183U 204.61 ± 4.71 0.039 ± 0.001 
 
Although initial experiments indicated that 24hr would be sufficient time to thoroughly 
anneal the dosimeters using the manual annealing lightbox, the average initial (background) 
dose prior to each experiment was monitored. This showed a notable and consistent 
increase in the average background dose over several weeks and experiments. 
As a result of this trend, a 36hr annealing experiment was performed to test if it was possible 
to ensure the background would always stay below the 0.1cGy limit set. The average 
background dose for the first 20 experiments conducted is shown in Figure 16, the 4th 
experiment was the final one performed following a 24hr anneal, all subsequent 
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experiments were performed after a 36hr anneal. Additionally, all experiments listed in the 
following chapters reference only those where a 36hr anneal was used as this was found to 
be more effective to keep background dose below the limit. 
 
Figure 16: Background dose trend after repeated use (95% confidence interval) 
3.2.4 Discussion 
Through methodical escalation of annealing time, a 36hr anneal time was selected which, 
whilst long and possibly not clinically ideal, ensured that the anneal was reliably thorough 
and complete. The 0.1cGy limit was chosen based on a combination of the level of precision 
required for low dose clinical investigations and the typical background of dosimeters that 
had not previously been irradiated. Other more intense sources of illumination could be used 
if the 36hr time becomes prohibitive however this is not foreseen to be an issue. 
3.3 Preliminary Investigation  - Batch Sensitivity 
Despite being manufactured from the same material and even from the same batch of the 




























Background increase with repeated use 
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otherwise identical detectors. Radiation induced damage or variations in dopant 
concentration in the crystalline structure can make one dosimeter slightly more or less 
sensitive than another [65].  
In an attempt to account for this, the Landauer NanoDots® are shipped with pre-assigned 
sensitivities. The derivation and meaning of these sensitivities however are not discussed in 
the supplied literature and the radiation source used is a Co-60 source which produces 1.17 
and 1.33MeV gamma rays. In order to correct for any energy dependent sensitivity variation 
between the discrete peaks of the Co-60 source and the higher energy spectrum delivered 
by a clinical linear accelerator, the manufacturer sensitivities were ignored and new batch 
sensitivity values were recalculated. Quoted results throughout the remainder of this work 
have had the manufacturer values factorised out. 
3.3.1 Aim 
To determine batch sensitivity values for 48 OSLs at 6 and 10 MV to account for energy 
dependence compared with manufacturer sensitivities as determined with a Co-60 source. 
3.3.2 Materials and Method 
The entire batch of 48 dosimeters were arranged in a 7 x 7 grid, excluding location 49, as 
shown in Figure 17 and placed at a depth of 10cm in solid water with 10cm of backscatter. 
The field size and number of monitor units were kept consistent throughout at 20cm x 20cm 
and 200MU respectively. Dosimeters were placed at 10cm depth to ensure a flat field across 
the grid which was independently verified prior to performing experiments using data 
gathered during normal clinical operation. For each round of experiments, every detector 
was read 3 times immediately before and 1hr after irradiation. Following readout, the batch 
was annealed for 36hrs and 3 full read-irradiate-read cycles were completed at both 6 and 




After significant investigation, the average sensitivity values are shown in Figure 18 and 
Figure 19 for 6 and 10 MV respectively. The relationship between dosimeter grid position 
and dosimeter ID number is also summarised in Table 4 and Figure 17. 
 
Figure 17: Arrangement of OSLs in grid positioned in beam field (shown in yellow) 













60896C 1 64739B 18 60947D 35 
04747N 2 64894D 19 37973M 36 
333602 3 82641O 20 86738A 37 
64519J 4 60897A 21 64904K 38 
60877C 5 36346Q 22 64754J 39 
60860R 6 86891G 23 36347O 40 
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64584M 7 56838C 24 647888 41 
64745I 8 57007W 25 04733W 42 
64345S 9 86906D 26 60892K 43 
56839A 10 569976 27 875698 44 
82663I 11 64523U 28 64545S 45 
56990K 12 86890I 29 57183U 46 
64885C 13 64726K 30 64549G 47 
64728E 14 60847F 31 64724O 48 
64324W 15 643402 32 
57193T 16 64722Q 33 
56992G 17 64579D 34 
 
 























Dosimeter Grid Poisition 





Figure 19: 10 MV Batch Sensitivity Averages (95% conf. int. shown) 
 
Figure 20: Variation in sensitivity at 6 & 10MV for each dosimeter (%) (95% conf. int. shown) 
3.3.4 Discussion 
Figure 18 and Figure 19 outline the relative batch sensitivities for 6 and 10 MV respectively 
with 95% confidence interval. It was found that there was minimal variation across the 
batch, with the highest sensitivity being 1.038 and lowest being 0.963, suggesting that 
despite the large number of factors that may affect OSL response, the NanoDot® has 



























Dosimeter Grid Position 







































These results were then used to examine the energy dependence. The sensitivity values 
obtained for each dosimeter at 6 and 10MV were divided and the deviation of this ratio from 
unity for each dosimeter is shown in Figure 20. The average of all 48 dosimeters was 1.0002 
± 0.0007 (or 0.02% difference in the sensitivity at 6 and 10MV) which indicates that 
NanoDot® OSLDs exhibit minimal energy dependence at therapeutic energies. This finding is 
supported by the work of Yukihara and McKeever [55], Akselrod [66], Viamonte, da Rosa, 
Buckley, Cherpak and Cygler [67], who found that at therapeutic energies NanoDot® energy 




4. DOSIMETER PROPERTIES 
4.1 Short Term Fading 
4.1.1 Introduction 
The role of NanoDot® OSLs in clinical practice primarily revolves around them being used for 
quick checks of sensitive volumes and margins. Due to the simple and quick readout 
procedure as well as their inherent robustness, they function as an excellent in vivo 
dosimeter. An intrinsic part of this is the ability to be read out rapidly without delaying 
further treatment as well as providing information about the effectiveness of a currently 
implemented treatment plan which may result in changes to the plan or its delivery method.  
Like any dosimeter, OSLs exhibit both short and long term fading. In the case of OSLDs this is 
due to spontaneous emission. Short term fading of materials that exhibit OSL is a very 
complex field. The appropriate mathematical description of emission probability is 
dependent on the material, temperature of readout, laser operation (continuous, linearly 
increasing or pulsed) and wavelength of laser used.  Due to the variability and complexity of 
emission formula, readers are directed to Botter-Jensen, McKeever and Wintle [68].  
In the case of the implementation of NanoDot® OSLs, long term fading is not clinically 
relevant and as such only short term fading was dealt with in this study. Since most clinical 
treatments involve regular visits and dosimeters will be read out within 48 hours, this was 
chosen as the time interval over which the fading was monitored. 
4.1.2 Aim 
To determine the short term fading characteristics of NanoDot® OSLs over a 48hr period. 
This will be achieved through readouts spaced across 48hrs with a higher number of readings 
in the initial 4hrs to accurately plot the steep signal decrease expected. 
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4.1.3 Materials and Method 
Since the time interval was substantial, the number of dosimeters used was determined by 
how many data points were required to adequately represent the fading curve. From 
previous literature[30, 35] it was determined that the region of most variation was the initial 
two hours. To adequately cover this region of rapid change, detectors were read out at 
1,2,5,10,15,30,60,120,240,360,480 minutes following irradiation, then over the subsequent 
two days at longer intervals.  
Prior to irradiation, all dosimeters were annealed for 36 hours and then read out three times 
to determine an average background dose. The experimental setup was as per Figure 21 and 
following irradiation each detector was left for one of the set time intervals and then read 
out three times in quick succession (taking roughly 30-45seconds).  
 
 
Figure 21: Experimental setup for 6 MV Short term fading 
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The detectors were arranged in a grid in the centre of a 20cm x 20cm field and irradiated by 
6 MV to 200MU at 10cm depth. 6 MV was used as this is the energy most commonly used 
clinically and similar results are expected at 10 MV. 
4.1.4 Results 
 
Figure 22: 6 MV Short Term Fading results with 95% confidence interval 
As shown in Figure 22, there is a significant drop in relative signal strength in the immediate 
time following irradiation however after this period the signal remains relatively stable for 
the remaining 48 hours. It was determined that it takes 30-60 minutes for the OSLD signal to 
stabilise which suggests this should be the waiting time between irradiation and readout for 
maximum accuracy and reliability. 
4.1.5 Discussion 
The significant (almost 20%) fading during the initial period following irradiation is expected 
from a solid state dosimeter as unstable traps lose electrons. This result however is 
























trend observed in the first 8 minutes following irradiation but may be attributed to 
hardening of the beam due to differences in experimental setup, giving an effectively higher 
energy beam. 
From the results obtained with this experimental set up and dosimeter batch, all future 
measurements were performed with a 45-60 minute wait time following irradiation to 
ensure adequate time was allowed for the signal to stabilise. Additionally, based on this 




4.2 Signal Loss Per Readout 
4.2.1 Introduction 
The mechanism behind OSL in Al2O3:C provides a stable system of signal retention if the 
dosimeter is not read. Through better PMT technology, this proportion of signal loss can be 
reduced, however the amount of signal loss from a reading and the number of reliable 
readings from a single dosimeter both need to be determined. 
The readout procedure of dosimeters is one important criterion to their use with passive and 
real time dosimeters having distinct advantages. In addition to this, some dosimeters can 
only be irradiated once such as film, whilst others measure accumulated dose before having 
the signal annealed and being re used. 
4.2.2 Aim 
To determine the proportion of signal loss as a result repetitive irradiation, readout and 
annealing. 
4.2.3 Materials and Method 
Similar to previous experiments, 5 dosimeters were irradiated by 200MU at 6 MV when 
positioned under 1cm of Superflab® and 0.5cm of solid water with 10cm back scatter. This 
experiment was conducted at dmax as the dose delivered was not being examined; only the 
relative signal drop during readout. Each dosimeter was readout three times before the 
experiment and then read 100 times in succession (to limit effect of short term fading). The 
background established before irradiation was then subtracted and previously determined 6 





Figure 23: Signal loss per readout for 5 dosimeters 
Figure 23 shows the effect of readout on signal loss, the procedure used for signal readout of 
OSLs allows for multiple readouts and is a major feature of solid state detectors. However, if 
a significant number of readouts are made the loss from readout needs to be accounted for. 
4.2.5 Discussion 
Through a line of best fit the rate of signal loss can be described mathematically. Although 
apparently linear the rate of signal loss is actually a proportion of signal retained in the traps. 
Whilst a linear fit would describe this data set and appear more pictorial, this is conditional 
on the number of readings remaining small. The exponential description is used here as it is 
more robust and better describes the underlying physical principle. Equation 22-24 shows 
the decay function for each dosimeter, where x is the repeat readout number. Equation 20 
shows the decay function of the average of all 5 dosimeters: 






























Equation 22: Decay function of dosimeter 645 84M 
 𝑦 = 0.9901𝑒−0.0004𝑥 (23) 
Equation 23: Decay function of dosimeter 647 45I 
 𝑦 = 0.9814𝑒−0.0004𝑥 (24) 
Equation 24: Decay function of dosimeter 647 26K 
 𝑦 = 0.9777𝑒−0.0004𝑥 (25) 
Equation 25: Decay function of dosimeter 645 19J 
 𝑦 = 0.9886𝑒−0.0005𝑥 (26) 
Equation 26: Decay function of dosimeter 047 33W 
 𝑦 = 0.9883𝑒−0.0005𝑥 (27) 
Equation 27: Average Rate of signal loss per readout 
This suggests that the signal loss per readout is 0.0005 (or approximately .05%) of the 
current signal. Whilst this is small, with multiple readouts it is necessary to correct for as the 
contribution to error can become significant. The observable drop in signal of 4% at 
approximately 40 readouts is noticeable for at least 3 of the 5 dosimeters. Beyond 40 
readings the dosimeter readout is observed to become unstable and remain unstable for 
subsequent readouts, this is particularly noticeable for 64726K (shown in red). Further 
investigation would be required to determine the cause of this effect, however the 40 
readouts required for this effect to present is significantly more than the 1 or 2 used 
clinically. As a result of this, it is advisable to limit clinical readouts to no more than 15-20, 






Multiple factors can affect the accuracy and precision of a reading, as such, determining the 
magnitude and cause of these factors is important to correct for those that are deemed 
significant. 
One such factor is the variation in a dosimeters’ response day-to-day. This can be caused by 
variation in the environmental conditions between days such as humidity and temperature, 
as well as variation in the radiation source. The sensitivity of OSLs to these variations needs 
to be determined before they are used clinically, although hospital conditions are 
maintained within the guideline provided by Workcover NSW [69] of 16-20oC and humidity 
of 40-70%, this may still be enough to cause variation in dosimeter response.  
4.3.2 Aim 
To examine the variation of OSL dosimeters over multiple days to determine day-by-day 
variation. 
4.3.3 Materials and Method 
As with previous experiments dosimeters will be irradiated with 100MU at 6 MV in a 10cm x 
10cm field. The 3 dosimeters used were irradiated separately and positioned in the centre of 
the field each time. The dosimeters were positioned at a depth of 6cm (5cm of solid water 
and 1cm of SuperFlab®), to provide a reference between measurements a 0.6cc Farmer 
Ionisation chamber was positioned at a further 5cm depth with 10cm of backscatter 
beneath. The ionisation chamber used was kept consistent throughout the experiment and a 
-300V bias was used. The experimental setup is pictured in Figure 24 for reference, note that 
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the depth was due to available solid water and does not affect results as only the relative 
signal is important. 
 
Figure 24: Reproducibility Setup 
The current from the ionisation chamber during irradiation was used to correct for 
temperature and pressure variations between measurements, both were determined prior 
to irradiation using an electronic temperature probe and electronic barometer. This 
information was then used according to TRS-398 to correct the signal; the equation for 
determining the factor, k, used to correct ionisation chamber measurements is shown in 







Equation 28: Correction factor, k, for ionisation chambers  
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Each dosimeter was read three times prior and post irradiation with the dose quoted as the 
difference between these two values. The values were then corrected by removal of the 
supplier sensitivities, then the batch sensitivities previously determined were applied. 
4.3.4 Results 
 
Figure 25: Dosimeter 64549G variation over 10 readouts 
 



































































Figure 27: Dosimeter 57183U variation over 10 readouts 
 
Figure 28: 0.6cc Farmer Ionisation chamber variation over 10 readouts 
The use of the Ionisation chamber as a reference is justified by Figure 28, where the error in 
the readings is at most ±0.05% with a portion of that most likely due to environmental or 
equipment variation. For the OSLDs however, at a 95% confidence interval the largest 






























































Across the 10 readings, the variation in the Ionisation chamber is negligibly small and could 
be put down to other factors such as cable noise. The OSLDs however had variation across 
the range of 2.84, 2.84 and 4.87% respectively, giving an average variation of 3.52 ± 0.998%. 
In most clinical cases, this will be of statistical significance and justifies the averaging of 
multiple readouts and/or multiple detectors to minimise this impact. Given the limited useful 
lifetime of the OSLDs, the use of 3 measurements per data was deemed sufficient when 




4.4 Dose Linearity 
4.4.1 Introduction 
Although all dosimeters record signal at all doses, due to a variety of intrinsic properties, 
detectors will only precisely record dose within a fixed range. The size and location of this 
range depends on the type of dosimeter and greatly varies. In the case of OSLDs for clinical 
use, a linear range of 0-200cGy would be the minimum required with a linear range up to 
500cGy, ideal to enable use of OSLDs on hypofractionated prostate and breast patients [70]. 
4.4.2 Aim 
To determine the linear range of response of OSLDs for clinical application through gradual 
dose escalation.  
4.4.3 Materials and Method 
Setup is identical to that shown in 4.3.3, however the dosimeter was positioned below 4cm 
of solid water and 1cm of SuperFlab®, and 10cm of backscatter material was positioned 
below. Prior to each set of measurements, the SuperFlab® was swapped with a 0.6cc Farmer 
ionisation chamber and a set of 3 chamber measurements were taken for reference. 
For each set of monitor units, 3 dosimeters were irradiated and each was read out 3 times 
prior and post irradiation. The average of these 9 readings was taken to represent each point 





Figure 29: OSLD and 0.6cc Farmer Ionisation chamber linearity up to 800MU (Maximum error 0.026%) 
Figure 29 plots the number of monitor units against the signal. Whilst the ionisation chamber 
has near perfect linearity across the entire range examined, the OSLD values vary. The data 
has been normalised to 100MU for easiest comparison and it can be seen that allowing for 
the impact of other factors discussed throughout this work, the data is approximately linear.  
4.4.5 Discussion 
Although the OSLDs do not display the same linearity as an ionisation chamber, in the range 
of interest for clinical investigations (0-500MU) they responded in a near linear fashion. The 
deviation from linearity is significant beyond 500MU. These results also agree with previous 
results obtained by: Jursinic [35], Hu, Wang and Zealey [71] & Viamonte, da Rosa, Buckley, 
Cherpak and Cygler [67]. The response of most clinical significance is in the range of 0-
200MU, which is also the region of best linearity, suggesting OSLDs would be appropriate 
































4.5 Dose Rate Dependence 
4.5.1 Introduction 
The mechanism of signal generation has been discussed extensively as it is the source of 
many of the characteristics unique to OSLs. In the case of dose rate dependence this is no 
different; the lifetime of the phosphorescence centres varies with the depth of the trap but 
will always be a finite value. In the case of Al2O3:C this is 35ms and signal stability will only 
occur once the rate of signal trapping balances the rate of thermal release [65].  
The rate of stimulation and excitation in OSLs can be described by similar simultaneous 
equations to those used for TLDs. Using numerical simulation and setting initial conditions to 
typical values, Chen and Leung [72] predicted dose rate dependence for OSLs. This is 
contrary to the numerical and empirical data gathered by Pingqiang, Zhaoyang, Yanwei, 
Turun and Yun [29] using CaS:Ce,Sm, however using the same system as is being examined 
here, Viamonte, da Rosa, Buckley, Cherpak and Cygler [67] obtained an increasing response 
with increasing dose rate. This wide range of results suggests that OSL dose rate dependence 
varies on conditions such as the type of OSL material being used. 
4.5.2 Aim 
To determine whether Al2O3:C OSLDs exhibit dose rate dependence under typical clinical 
conditions, by exposure to multiple dose rates. 
4.5.3 Materials and Method 
The experimental setup was identical to that used for the Reproducibility investigation (see 
4.3.3 and Figure 24 for details and diagram). For consistency with other experiments 6 MV 






Figure 30: Dose rate dependence 
Figure 30 shows the change in detector response with variation in dose rate, the signal has 
been normalised to 100MU/min and an increased response can be seen with increasing dose 
rate. 
4.5.5 Discussion 
The results of this experiment agree with those obtained by Viamonte, da Rosa, Buckley, 
Cherpak and Cygler [67] with almost identical results obtained within experimental error 
(95% confidence interval). This suggests that in the case of Al2O3:C NanoDot® OSLDS, a dose 
rate dependence can be observed and due to the statistical significance of this dependence, 
approximately 5%, the impact of dose rate will need to be considered to ensure accuracy and 



























Dose Rate (MU/min) 






electrons becoming trapped with a higher dose rate, this would give an increased signal at 




4.6 Angular Dependence 
4.6.1 Introduction 
As discussed in 4.2.3, Al2O3:C OSLDs have been shown to vary in signal as much as 4% in a 6 
MV clinical radiation beam. Given the primary application of these OSLDs will be for in vivo 
dosimetry and regions of interest on the patients’ surface are rarely perpendicular to the 
beam, a thorough understanding of the angular dependence of OSLDs will be critical to their 
clinical use. 
4.6.2 Aim 
To examine the OSLDs at multiple angles to determine the magnitude of angular 
dependence. 
4.6.3 Materials and Method 
For this experiment a jig was fashioned out of solid water and Perspex to encase the OSLD 
and allow it to be positioned at a desired angle to the beam with a precision of 1o (shown in 
Figure 32). The Perspex cylinder was machined to tightly fit an OSLD and fit inside the block 
of solid water, minimising air gaps. To ensure the cut-out within the cylinder was positioned 
directly below the centre of the solid water, (shown by the intersection of the black lines on 
the top of the block) a small steel ball used in clinical image registration was stuck in the cut-
out and an image was obtained with the linacs’ OBI and is shown in Figure 31 to be 0.03cm 




Figure 31: OBI image of steel fiducial in Perspex cylinder 
.  
Figure 32: Angular Dependence Jig (The University of Wollongong) 
This jig was placed between two 10cm slabs of solid water in a 6cm x 6cm field at 6 MV and 
irradiated by 100MU as shown in Figure 33. A 6cm square field was chosen as the jig was 





Figure 33: Angular Dependence Setup 
Data points were obtained at 20 degree intervals around the entirety of the circle with three 
OSLDs used at each data point. As with previous measurements each OSLD was measured 
three times prior and post irradiation with the dose quoted the difference in the average of 
these readings. Due to the large number of readings and limited access time to the linac, the 
data was obtained in multiple sessions, as such each day a data point was obtained 





Figure 34: Angular Dependence of OSLDs 
Figure 34 shows the variation of signal across 360o with error bars showing a 95% confidence 
interval. The variation of this data is 0.94-1.04 suggesting a ±4% range depending on the 
orientation of the dosimeter to the field. 
4.6.5 Discussion 
The result of this experiment (±4% angular dependence) agrees with those obtained by 
Kerns, Kry, Sahoo, Followill and Ibbott [58], Sharma and Jursinic [61] and Viamonte, da Rosa, 
Buckley, Cherpak and Cygler [67]. Jursinic [35] however, claims that OSLs have no angular 
dependence “within measurement uncertainty (0.9%)”. The response in Figure 34 includes 
two regions of over response, between 100o-160o and between 320o-340o; this is either the 
result of low signal in the 0o reading to which subsequent reading are normalised to, or an 
unavoidable artefact of the chip construction which causes a different path length through 
plastic depending on the angle of the chip to the beam. Due to the symmetry of the OSLDs, 



































4.7 Depth Dose Curve 
4.6.6 Introduction 
The use of OSLDs for in vivo measurements, particularly for those being used in clinical 
considerations, needs to be justified by their performance with little to no “build-up” 
material. The best way to examine this performance is through the creation of a depth dose 
curve and comparison with another in vivo dosimeter. By examining the build-up region of 
the depth dose curve the need for correction factors can be established or if required build-
up caps can be fashioned to artificially improve a dosimeters’ performance in the build-up 
region. 
4.6.7 Aim 
To examine the performance of OSLDs and EBT3 radiochromic film at a variety of depths.  
4.6.8 Materials and Method 
Figure 35 shows the experimental setup for the OSL investigation, the shaded solid water 
(maroon) was gradually increased in thickness with subsequent measurements while a 
100cm SSD was maintained throughout the experiment. As the only previous method of 
reducing air gaps was a piece of SuperFlab© 1cm in thickness, a 1cm thick piece of solid 
water had a recess milled to precisely hold a single OSLD in the centre. This allowed pieces of 





Figure 35: Depth Dose Setup 
For comparison, EBT3 Gafchromic film was put through an identical experiment. Initially the 
film was prescanned 12 times and then cut into 3cm squares, 3 squares were used at each 
depth and the average dose was determined by post irradiation scanning and reading of the 
red channel counts. This number of counts in the red channel, was then converted to dose 
by comparison to a calibration curve obtained prior. This curve was obtained by using a 
known field setup giving a known dose and irradiating squares from the same piece of film at 
a range of known doses. Figure 36 shows an image of the sheet of EBT3 prior to prescanning 
with squares marked out showing 3cm squares. 
For the Attix Ionisation Chamber measurements a 0.125cm3 Gammex® Attix chamber was 
used, the experimental setup for this was identical to those using the Farmer chamber in 
previous experiments with a piece of recessed solid water removing air around the detector 




Figure 36: Sheet of EBT3 with 3cm grid marked out 
4.6.9 Results 
 
Figure 37: EBT3 Radiochromic film calibration curve (Maximum error 1%) 
 





























Figure 38: OSL, EBT3 and Attix Ion Chamber normalised depth dose at 6MV (95% conf. int. not visible) 
4.6.10 Discussion 
The calibration curve shown in Figure 37 was calculated using film squares cut from the same 
piece of film and irradiated at the same time as the film used to develop the depth dose 
curve. The setup in determining the calibration curve involved placing the film beneath 
1.5cm of solid water and irradiating with known monitor units at 6MV. This arrangement was 
used as the linac being used was commissioned to deliver 1cGy/MU with this setup. The 
equation shown was then used to relate the optical density values in Figure 38 to dose as 
shown in Equation 29: 
 𝑂𝐷 = (0.0029 ∗ 𝐷𝑜𝑠𝑒) + 0.2095 
0.0029 ∗ 𝐷𝑜𝑠𝑒 = 𝑂𝐷 − 0.2095 
Hence, 







































When presented as a normalised response on the same graph, as seen in Figure 38, the 
relative depth dose curve beyond 0mm is strikingly similar. Given the expected normalised 
response values based upon theory and other literature (see McCaw et al [73]), the 
agreement of these values provides reliability to the experimental procedure. The over 
response of the OSLDs at the surface is to be expected due to insufficient build up material 
being present. 
For the Attix Chamber measurements, relative dose is the quoted value. This figure was 
determined by taking the average charge recorded at 10cm depth for a 10cm x 10cm field 
and dividing this value by 0.661, this value was determined at commissioning of the machine 
and corrects the 10cm deep value to dmax. Since the machine delivers 100cGy at dmax with a 
10cm x 10 cm field, this charge value was then used as a known proportionality to convert 
the charge values measured to a relative dose in cGy. This was performed to provide an 
easier comparison with the OSL and EBT3 values. The results obtained by this method gave 
values accurate to other literature for depth dose curves with a dmax relative dose of 
100.57cGy and a surface value of 15.49cGy [74].  
73 
 
5. MEPITEL® FILM 
5.1 Effect of Mepitel® Film on surface dose 
5.1.1 Introduction 
Despite the massively positive effects of radiotherapy, a number of negative side effects can 
make treatment a difficult and trying process for patients who are already ill. Whilst 
treatments are designed to balance treatment effectiveness and a base level of patient 
comfort, improving patient comfort is always an excellent way of improving treatment. 
Below are some common side effects of radiotherapy treatments, for each of these there is 
research into methods of reducing the both the severity and incidence rate. In addition to 
those listed, specific treatment sites each have their own complications and side effects [1, 
75]. 
 Moist Desquamation: A painful condition caused as a result of severe damage to 
the basal cells of the skin. As a result of this damage the skin begins to ooze and 
can lead to infection at the affected area. 
 Erythema: Reddening of the skin caused by radiation damage to the dermal or 
sub dermal layers of the skin. 
 Change in hair colour or texture, including permanent hair loss 
 Telangiectasia: Spider-web like marks on the skin from damage to superficial 
blood vessels. 
 Lymphoedema: Blockage of the lymphatic system resulting in swelling of the 
extremities. 
 Changes in fertility including permanent sterility 
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 Fibrosis (stiffening of tissue) causes a variety of complications depending on 
region affected including: regional swelling, shortness of breath, difficulty 
swallowing, incontinence and diarrhoea. 
 Tiredness ranging in severity which often increases over treatment course 
Skin cells are amongst the most sensitive to radiation and as a result, radiotherapy often 
causes complications with the patients’ skin. One emerging technology for minimising the 
severity of radiotherapy induced skin conditions is Mepitel ® film. This film consists of a thin 
silicone film with an applied adhesive.  The film protects the skin by maintaining a moist 
environment by allowing only excess moisture to evaporate without being non-permeable 
enough to protect from microbial contamination. 
A recent phase iii trial by Herst, Bennett, Sutherland, Peszynski, Paterson and Jasperse [76] 
showed promising findings when using Mepitel® film compared to conventional topical 
treatments such as corticosteroids, hyaluronic acid and aloe vera. The patients who were 
treated with topical creams had radiation induced skin reactions that progressed to moist 
desquamation in 26% of patients.  Only 44% of those patients who had the Mepitel® film 
applied during and post treatment developed any form of skin condition and none of these 
progressed to moist desquamation. However as shown in the previous chapter, in the first 
few millimetres of material there is significant build up in dose and although the film is 
extremely thin, the dose build-up of the material at least needs to be investigated. In 
addition to this the different mass energy absorption coefficient for the silicon of the film is 
different to the air and soft tissue on either side (
𝜇𝑒𝑛
𝜌
 for silicon is 0.01827cm2g-1 compared to 
0.01647 and 0.01786 cm2g-1 for air and soft tissue respectively)[77]. Because of this, concern 
exists around the effect of using Mepitel® on the conformity of the dose and consequently 




To determine if the application of Mepitel® Film on a patient, has significant effect on the 
surface dose to the area. Primarily through examination of the build-up effect of Mepitel® by 
using OSLDs. 
5.1.3 Materials and Method 
For this experiment, sequences of measurements were taken using both OSLDs and a 
Gammex® 0.125cc Attix Ionisation Chamber. 10cm of solid water was used as backscatter 
material and a 10cm x 10cm field at 100cm SSD was set up. 100MU were delivered with and 
without the presence of the film as well as a measurement at 10cm depth to provide a frame 
of reference. A 10cm x 10cm field at 100cm SSD was used as the linac had been calibrated to 
deliver 1cGy/MU with these settings. This process was then repeated at 10 MV to give a 
broader clinical relevance. 
5.1.4 Results 
 
Figure 39: Build up effect of Mepitel® Film measured using OSL and Attix Ionisation Chamber (95% 
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Figure 39 shows that Mepitel® has the effect of increasing surface dose to the patient, the 
degree to which this occurs however is not as clear. The OSLDs recorded an increase in dose 
from 40.555cGy to 41.646cGy for 6 MV. However, the Attix chamber recorded an increase of 
15.584cGy to 19.587cGy for 6 MV. The Attix Chamber is commonly used for investigation in 
the build-up region and as such these values are likely more precise. The 25.68% increase 
measured by the Attix chamber is much closer than the OSLDs, to the 13% increase 
measured by Butson, Cheung, Yu and Metcalfe [78] for a 10cm x 10 cm field at 6 MV. 
Additionally Butson, et al. observed a decreased build up effect for the film with increasing 
field size and a decreased accuracy using TLDs compared to an Attix chamber. Another 
experiment conducted by Haas and Coletti [79] found an increase in skin bolus of 30-58% for 
a variety of dressings including Mepitel. Due to the nature of the publication however, no 




The Landauer NanoDot® OSLD system has proven useful for radiotherapy treatment 
verification through several clinically desirable: The ease with which the system can become 
operational, the robustness of the OSLDs and the ease of readout are all beneficial 
properties of a clinical system. 
Understanding the magnitude of factors affecting detector response is critical to accurate 
readings and consequently the value of OSLs to the treatment process as a whole. From 
investigation of the literature it was determined that short term fading, signal loss per 
readout, dose variation as well as linearity, dose rate, angular and depth dose dependence 
are all important quantities. In addition to this, operation of the Gammasonics® manual 
annealing lightbox and calculation of the relevant batch sensitivity values were investigated 
to ensure completeness of this study. 
The values of the quantities mentioned fell within acceptable limits when compared with 
other dosimeters and previous NanoDot® investigations. This suggests that in terms of dose 
accuracy, OSLDs are at worst comparable with currently used technology. The 164% over 
response in the first 2mm and the ±4% angular dependence are both of particular relevance 
when NanoDots® are used for in vivo measurements. The signal measured shows excellent 
stability after a 20% decrease over the first 30 minutes and can be read multiple times with 
only a 0.05% decrease in signal per readout. The 5% dose rate dependence and variation 
over multiple readouts are both useful quantities to know. 
When applied to a clinical investigation, it was found that Mepital® film caused an increase in 
build-up of surface dose. Although the magnitude determined of this increase by OSL 




With careful setup, including the determination of an appropriate calibration factor, as well 
as occasional QA checks, using the calibrated NanoDots® to provide adequate dose accuracy 
is possible. With dose values theoretically as accurate as a ten thousandth of a Gray possible 
and a readout procedure of only a few seconds, the NanoDot® system allows the end user to 
determine the accuracy of their system based on needs.  
For day to day use of NanoDots® with minimal time investment into set up and calibration, 
whilst still accounting for the wide number of factors affecting dose accuracy, a dose 
accuracy of 5% should be expected. This is based on a 36hr anneal to ensure a initial dose of 
no more than 0.1cGy and a readout procedure involving the averaging of 3 readouts 
following a 30 minute waiting period. For simple clinical investigation this is anticipated to be 
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